Study Justifies L-DOPA Therapy for Angelman Syndrome (IMAGE)

University of North Carolina Health Care

Study Justifies L-DOPA Therapy for Angelman Syndrome

Caption

This is an in vivo voltammograms showing higher dopamine (DA) release in the nucleus accumbens (NAc) and lower release in the dorsal striatum of Angelman syndrome model mice (Ube3a m-/p+) compared to wild-type mice (WT).

Credit

Image courtesy of C.J. Malanga, MD, PhD

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.